NCT05690165

Brief Summary

The goal of this clinical trial is to study the effects of aerobic exercise during the early rehabilitation after ischemic stroke. The main questions it aims to answer are:

  • How is the recovery of motor function affected by regularly walking during the first 90 days after an ischemic stroke?
  • Does regularly walking during the first 90 days after ischemic stroke affect cognition, physical comfort and the immune system? Participants will exert a heart rate controlled walking programme of walking 3-5 times 30-45 minutes per week. Researchers will compare the recovery of the walking group to a control group without any demands regarding physical exercise.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
39

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Oct 2022

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

October 26, 2022

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

December 20, 2022

Completed
1 month until next milestone

First Posted

Study publicly available on registry

January 19, 2023

Completed
11 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2023

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

February 1, 2024

Completed
Last Updated

June 3, 2024

Status Verified

May 1, 2024

Enrollment Period

1.1 years

First QC Date

December 20, 2022

Last Update Submit

May 31, 2024

Conditions

Keywords

Motor FunctionAerobic ExerciseImmune SystemCognition

Outcome Measures

Primary Outcomes (1)

  • Motor function

    Recovery of motor function is assessed by fugl-meyer assessment (FMA). The FMA-UE (upper extremity) is measured in a score with a maximum of 66 points for motor function, the FMA-LE (lower extremity) extends up to a sum score of 34 points for motor function.

    90 days

Secondary Outcomes (5)

  • Cognition

    90 days

  • Fatigue

    90 days

  • Physical Comfort

    90 days

  • Flow cytometry analysis of cryoasservated peripheral blood mononuclear cells (PBMC)

    90 days

  • Structural axonal changes

    90 days

Study Arms (2)

Exercise Group

EXPERIMENTAL

Participants will exert a heart rate controlled aerobic walking training 3-5 times per week for 30-45 minutes per training. This exercise as well as the daily amount of steps will be assessed via smartwatch.

Behavioral: Walking Exercise

No Exercise Group

NO INTERVENTION

Participants receive no demands regarding the daily exercise. Their daily amount of steps will be assessed via smartwach.

Interventions

Heart rate controlled walking exercise

Exercise Group

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • initial NIHSS or NIHSS determined at the moment of maximum deterioration 1-18
  • age \> 18
  • ischemic stroke
  • pre-stroke independence
  • sufficient motivation / patient's desire to cooperate / exercise for 3-5x/week for 30-45 min

You may not qualify if:

  • transient ischemic attack
  • premorbid motor disability / musculoskeletal injury / severe arthritis impairing degree of movement
  • balance and transfer function that requires assistance
  • cardiac disease not allowing to perform aerobic training
  • inability to give informed consent

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

University Hospital Münster

Münster, Northrine-Westphalia, D-48149, Germany

Location

Related Publications (1)

  • Straeten FA, van Zyl S, Maus B, Bauer J, Raum H, Gross CC, Bruchmann S, Landmeyer NC, Faber C, Minnerup J, Schmidt-Pogoda A. EXERTION: a pilot trial on the effect of aerobic, smartwatch-controlled exercise on stroke recovery: effects on motor function, structural repair, cognition, mental well-being, and the immune system. Neurol Res Pract. 2023 May 11;5(1):18. doi: 10.1186/s42466-023-00244-w.

MeSH Terms

Conditions

Ischemic Stroke

Condition Hierarchy (Ancestors)

StrokeCerebrovascular DisordersBrain DiseasesCentral Nervous System DiseasesNervous System DiseasesVascular DiseasesCardiovascular Diseases

Study Officials

  • Antje Schmidt-Pogoda, MD

    University Hospital Muenster

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

December 20, 2022

First Posted

January 19, 2023

Study Start

October 26, 2022

Primary Completion

December 1, 2023

Study Completion

February 1, 2024

Last Updated

June 3, 2024

Record last verified: 2024-05

Data Sharing

IPD Sharing
Will not share

Locations